Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection
Clinical trial NCT02041247 · UNKNOWN
Trial details
- NCT number
- NCT02041247
- Sponsor
- InnaVirVax
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.